Short-term efficacy and influencing factors of conventional chemotherapy combined with irinotecan in patients with advanced gastric cancer

Table 3 Comparison of clinical data of effective and ineffective patients in observation group

Clinical data	Chemotherapy effective (n = 23)	Chemotherapy ineffective (n = 17)	t/χ2 value	P value
Gender, n (%)			0.051	0.822
Male	13 (56.62)	9 (52.94)
Female	10 (43.48)	8 (47.06)
Age (yr)	60.60 ± 5.56	65.12 ± 5.71	-3.587	0.001
Body mass index (kg/m2)	22.14 ± 2.03	22.75 ± 2.12	-1.314	0.193
KPS score (points)	75.54 ± 4.32	67.70 ± 3.83	8.589	0.000
TNM stages, n (%)			5.631	0.018
IIIb	19 (82.61)	8 (47.06)
IV	4 (17.39)	9 (52.94)

KPS: Karnofsky Performance Scale; TNM: Tumor node metastasis.